Common Contracts
2 similar Asset Purchase Agreement contracts by Biofrontera Inc., Pelthos Therapeutics Inc.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 7th, 2025 • Pelthos Therapeutics Inc. • Biological products, (no disgnostic substances) • Delaware
This ASSET PURCHASE AGREEMENT (as may be amended, restated, supplemented or otherwise modified in accordance with Section 7.6 this “Agreement“), dated as of November 6, 2025 (the “Agreement Date“), is made and entered into by and between Pelthos Therapeutics Inc., a Nevada corporation (“Purchaser“), and Biofrontera Inc., a Delaware corporation (“Seller“). Seller and Purchaser are collectively referred to herein as the “Parties“ and each individually as a “Party“. Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in Article I.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 7th, 2025 • Biofrontera Inc. • Pharmaceutical preparations • Delaware
This ASSET PURCHASE AGREEMENT (as may be amended, restated, supplemented or otherwise modified in accordance with Section 7.6 this “Agreement”), dated as of November 6, 2025 (the “Agreement Date”), is made and entered into by and between Pelthos Therapeutics Inc., a Nevada corporation (“Purchaser”), and Biofrontera Inc., a Delaware corporation (“Seller”). Seller and Purchaser are collectively referred to herein as the “Parties” and each individually as a “Party”. Capitalized terms used herein and not otherwise defined shall have the meanings ascribed to them in Article I.